Health Care: Drugs
MannKind Corporation (MNKD: NASDAQ)
$5.31 0.12 | 2.31%
05/20/13 - 04:00 PM ET
Partner Headlines for MNKD
- Mid-Afternoon Market Update: Markets Remain Down, Bankrate Rallies - Benzinga 04.12.13 | 03:04 pm
- Long MannKind's Afrezza: Shares Versus A Bull Call Spread - Seeking Alpha 12.01.12 | 07:12 am
- MannKind to Raise Funds - Analyst Blog - Zacks 10.18.12 | 07:10 pm
- MannKind Announces Pricing of Public Offering of Common Stock and Warrants - Benzinga 10.18.12 | 09:10 am
- MNKD Enrolls Patients for Afrezza - Analyst Blog - Zacks 10.08.12 | 06:10 pm
- Company News for September 05, 2012 - Corporate Summary - NASDAQ 09.05.12 | 02:09 pm
- Weekly CFO Buys Highlight: CPRX, APPY, MEI, MNKD - GuruFocus 07.09.12 | 01:07 pm
- Weekly Top Insider Buys: HRB, LPI, GCO, GAM, SONC, MNKD - GuruFocus 07.09.12 | 01:07 pm
- A123 Systems POPS to Lead 7 NASDAQ Top Percentage Winners - Wall St. Cheat Sheet 06.21.12 | 11:06 am
- MNKD Cancer Treatment Data Released - Analyst Blog - Zacks 06.01.12 | 06:06 pm